Tivity Health - TVTY Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $32.00
  • Forecasted Upside: -1.54 %
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$32.50
+0 (0.00%)

This chart shows the closing price for TVTY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Tivity Health Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for TVTY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TVTY

Analyst Price Target is $32.00
▼ -1.54% Downside Potential
This price target is based on 3 analysts offering 12 month price targets for Tivity Health in the last 3 months. The average price target is $32.00, with a high forecast of $35.00 and a low forecast of $30.00. The average price target represents a -1.54% upside from the last price of $32.50.

This chart shows the closing price for TVTY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 3 investment analysts is to hold stock in Tivity Health. This rating has held steady since August 2021, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings
4/14/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 0 sell ratings
7/13/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 0 sell ratings
10/11/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 0 sell ratings
1/9/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 0 sell ratings
4/9/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 0 sell ratings
7/8/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
9/6/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
10/6/2022

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/5/2022Barrington ResearchDowngradeOutperform ➝ Market PerformLow
3/11/2022Credit Suisse GroupBoost TargetNeutral$29.00 ➝ $31.00Low
2/25/2022Barrington ResearchBoost Target$33.00 ➝ $35.00High
2/24/2022William BlairReiterated RatingMarket PerformMedium
1/7/2022Credit Suisse GroupUpgradeUnderperform ➝ Neutral$25.00 ➝ $29.00High
1/5/2022Truist FinancialBoost Target$28.00 ➝ $30.00High
11/9/2021Credit Suisse GroupBoost TargetUnderperform$21.00 ➝ $25.00Low
11/3/2021Barrington ResearchBoost TargetOutperform$31.00 ➝ $33.00High
8/23/2021Truist FinancialLower TargetHold$28.00 ➝ $25.00Low
8/5/2021Cantor FitzgeraldLower TargetOverweight$36.00 ➝ $33.00High
8/5/2021Piper SandlerLower TargetNeutral$27.00 ➝ $25.00High
6/9/2021Cantor FitzgeraldBoost TargetOverweight$32.00 ➝ $36.00High
2/26/2021Credit Suisse GroupBoost TargetUnderperform$19.00 ➝ $20.00Medium
2/25/2021Piper SandlerBoost Target$16.00 ➝ $27.00Low
2/25/2021Barrington ResearchBoost TargetOutperform$28.00 ➝ $32.00High
1/15/2021Credit Suisse GroupDowngradeNeutral ➝ Underperform$19.00Low
1/5/2021Truist FinancialBoost Target$18.00 ➝ $22.00N/A
11/23/2020GuggenheimUpgradeNeutral ➝ BuyHigh
11/17/2020Cantor FitzgeraldUpgradeNeutral ➝ Overweight$25.00Low
11/6/2020Piper SandlerBoost TargetNeutral$10.00 ➝ $16.00High
10/30/2020Jefferies Financial GroupUpgradeHold ➝ Buy$14.50 ➝ $20.00Low
8/6/2020Barrington ResearchBoost TargetOutperform$15.00 ➝ $27.00High
8/6/2020Craig HallumUpgradeHold ➝ Buy$10.00 ➝ $20.00High
6/12/2020GuggenheimInitiated CoverageNeutralLow
5/21/2020SunTrust BanksBoost TargetHold$10.00 ➝ $11.00Medium
5/12/2020SunTrust BanksBoost TargetHold$7.50 ➝ $10.00High
5/7/2020Barrington ResearchLower TargetOutperform$24.00 ➝ $15.00High
4/13/2020SunTrust BanksLower TargetHold$15.00 ➝ $7.50High
3/16/2020Credit Suisse GroupReiterated RatingHold$11.00High
3/16/2020Craig HallumLower TargetHold$18.00 ➝ $4.00High
2/20/2020Piper SandlerLower Target$25.00 ➝ $15.00High
2/20/2020Barrington ResearchReiterated RatingBuy$24.00High
2/20/2020Craig HallumDowngradeBuy ➝ Hold$18.00High
2/20/2020Jefferies Financial GroupDowngradeBuy ➝ Hold$16.00High
2/20/2020William BlairDowngradeOutperform ➝ Market PerformHigh
2/20/2020Cantor FitzgeraldDowngradeOverweight ➝ Neutral$40.00 ➝ $17.00High
2/20/2020SunTrust BanksDowngradeBuy ➝ Hold$15.00High
2/14/2020OppenheimerInitiated CoverageBuy$32.00Medium
1/27/2020Piper SandlerDowngradeOverweight ➝ Neutral$25.00Low
1/21/2020Cantor FitzgeraldReiterated RatingOverweight$45.00 ➝ $40.00Medium
1/3/2020Credit Suisse GroupInitiated CoverageNeutral$22.00High
12/23/2019Barrington ResearchReiterated RatingBuy$38.00Medium
8/26/2019Cantor FitzgeraldSet TargetBuy$45.00Low
8/23/2019Chardan CapitalLower TargetBuy$33.00 ➝ $24.00High
8/8/2019Barrington ResearchReiterated RatingOutperformMedium
8/8/2019Piper Jaffray CompaniesLower TargetOverweight$33.00 ➝ $25.00High
5/10/2019Barrington ResearchSet TargetBuy$40.00Medium
5/9/2019OppenheimerBoost Target$31.00 ➝ $36.00High
5/9/2019Cantor FitzgeraldBoost TargetOverweight$40.00 ➝ $45.00High
5/9/2019Piper Jaffray CompaniesBoost TargetOverweight$29.00 ➝ $33.00High
4/22/2019Cantor FitzgeraldReiterated RatingBuyLow
4/11/2019Craig HallumInitiated CoverageBuy$30.00Low
2/20/2019Jefferies Financial GroupLower TargetBuy$29.00Medium
2/20/2019Piper Jaffray CompaniesLower TargetOverweight$29.00High
2/20/2019Barrington ResearchReiterated RatingOutperform$40.00High
2/20/2019Cantor FitzgeraldReiterated RatingOverweight$40.00High
2/20/2019SunTrust BanksLower TargetBuy$28.00High
2/1/2019Chardan CapitalReiterated RatingBuy ➝ Buy$41.00 ➝ $31.00Low
12/17/2018Cantor FitzgeraldLower TargetOverweight ➝ Overweight$52.00 ➝ $49.00Low
12/11/2018OppenheimerLower TargetOutperform$44.00 ➝ $34.00Low
11/6/2018Barrington ResearchReiterated RatingBuy$50.00Medium
11/6/2018Chardan CapitalLower TargetBuy$43.00 ➝ $41.00High
11/5/2018Cantor FitzgeraldReiterated RatingBuy$49.00High
8/3/2018SunTrust BanksReiterated RatingBuy$46.00Medium
6/4/2018Chardan CapitalUpgradeNeutral ➝ Buy$42.00Medium
4/24/2018Piper Jaffray CompaniesReiterated RatingBuy$49.00High
4/23/2018Cantor FitzgeraldReiterated RatingBuy$53.00High
2/23/2018Barrington ResearchBoost TargetOutperform ➝ Outperform$40.00 ➝ $47.00High
2/23/2018Cantor FitzgeraldReiterated RatingOverweight$53.00High
2/23/2018Chardan CapitalReiterated RatingNeutral ➝ Neutral$44.00 ➝ $41.00High
11/7/2017Barrington ResearchReiterated RatingOutperform ➝ Outperform$46.00 ➝ $40.00N/A
11/6/2017Cantor FitzgeraldReiterated RatingBuy$45.00N/A
11/1/2017OppenheimerBoost TargetOutperform$47.00 ➝ $50.00N/A
10/27/2017SunTrust BanksSet TargetBuy$50.00N/A
10/27/2017Chardan CapitalReiterated RatingNeutral ➝ Neutral$40.00 ➝ $44.00N/A
10/12/2017SunTrust BanksReiterated RatingBuy$46.00N/A
(Data available from 10/6/2017 forward)

News Sentiment Rating

0.24 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/10/2022
  • 7 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/9/2022
  • 2 very positive mentions
  • 5 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
5/9/2022
  • 2 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/8/2022
  • 2 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/8/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/7/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/6/2022
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/6/2022

Current Sentiment

  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Tivity Health logo
Tivity Health, Inc. provides fitness and health products and solutions in the United States. The company offers SilverSneakers to members of Medicare Advantage, Medicare Supplement, and group retiree plans; Prime Fitness, a fitness facility access program through commercial health plans, employers, and other sponsoring organizations; virtual fitness experiences, including live instructor-led classes; and WholeHealth living program, a continuum of services related to complementary, alternative, and physical medicine. It also provides Wisely Well brand meals designed to support individuals and caregivers who are seeking meal convenience, as well as those recovering after a hospitalization or living with chronic conditions. The company was formerly known as Healthways, Inc. and changed its name to Tivity Health, Inc. in January 2017. Tivity Health, Inc. was incorporated in 1981 and is headquartered in Franklin, Tennessee.
Read More

Today's Range

Now: $32.50
Low: $32.50
High: $32.50

50 Day Range

MA: $32.50
Low: $32.50
High: $32.50

52 Week Range

Now: $32.50
Low: $21.25
High: $32.89

Volume

1,170 shs

Average Volume

820,051 shs

Market Capitalization

$1.62 billion

P/E Ratio

19.01

Dividend Yield

N/A

Beta

2.14

Frequently Asked Questions

What sell-side analysts currently cover shares of Tivity Health?

The following equities research analysts have issued stock ratings on Tivity Health in the last twelve months: Barrington Research, Credit Suisse Group AG, StockNews.com, Truist Financial Co., and William Blair.
View the latest analyst ratings for TVTY.

What is the current price target for Tivity Health?

3 Wall Street analysts have set twelve-month price targets for Tivity Health in the last year. Their average twelve-month price target is $32.00, suggesting a possible downside of 1.5%. Barrington Research has the highest price target set, predicting TVTY will reach $35.00 in the next twelve months. Truist Financial Co. has the lowest price target set, forecasting a price of $30.00 for Tivity Health in the next year.
View the latest price targets for TVTY.

What is the current consensus analyst rating for Tivity Health?

Tivity Health currently has 3 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in TVTY, but not buy more shares or sell existing shares.
View the latest ratings for TVTY.

What other companies compete with Tivity Health?

How do I contact Tivity Health's investor relations team?

Tivity Health's physical mailing address is 701 Cool Springs Boulevard, Franklin TN, 37067. The company's listed phone number is (800) 869-5311 and its investor relations email address is [email protected] The official website for Tivity Health is www.tivityhealth.com. Learn More about contacing Tivity Health investor relations.